|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review Article |
1 Division of Cardiovascular Medicine, University of California, Davis, CA 95616, USA 2 Vallabh Bhai Patel Chest Institute, University of Delhi, Delhi, India
| Abstract |
|---|
|
|
|---|
(Received 9 January 2006;
accepted after revision 21 March 2006; first published online 26 June 2006)
Corresponding author C. Tissa Kappagoda: TB 172 Division of Cardiovascular Medicine, One Shields Avenue, University of California, Davis, CA 95616, USA. Email: ctkappagoda{at}ucdavis.edu
| Introduction |
|---|
|
|
|---|
receptors have been demonstrated in the tracheal epithelium of guinea-pigs. These receptors have cell bodies in the jugular ganglia (Riccio et al. 1996; Undem & Carr, 2001; Undem et al. 2002). Even though these receptors also adapt rapidly to a maintained mechanical stimulus, their sensitivity to some chemicals varies from the conventional RARs (Widdicombe, 2003). Recently, neuroepithelial bodies (NEBs) located in the airways, with afferents in the vagi and spinal nerves, have been reported (Adriaensen et al. 1998). The laryngeal RAR, tracheal A
receptors and airway NEBs will not be discussed in the present review.
The first description of RAR was provided by Keller & Loeser (1930). However, one of the earliest recordings of discrete action potentials in the cervical vagus was reported by Adrian (1933), who observed that while some of the sensory receptors in the lung were stimulated by inflation, a few others were stimulated by forced deflation. The first formal description of RAR was provided by Knowlton & Larrabee (1946), who reported that among the vagal afferents which responded to lung inflation, approximately two-thirds responded with a sustained increase in activity. The remaining one-third showed a sharp increase in activity which adapted within a few seconds of inflation (Fig. 1). The term Rapidly Adapting Receptors was applied to the latter group of sensory endings. Based upon their conduction velocities (835 m s1), the nerve fibres originating from these receptors indicated that they were myelinated. Knowlton & Larrabee (1946) defined an adaptation index (AI) also to identify RAR:
|
|
70% was the best indicator for identifying the RAR described by Knowlton & Larrabee (1946) previously. He also attempted to identify the natural stimulus for the RAR using various inflation volumes and techniques to alter the flow of air in the airways. His overall conclusion was that lung collapse and its reversal excited far more RAR than distension and its release. Even though many of them showed irregular resting activity, respiratory modulation was seen in some. However, they did not exhibit a fixed timing with the phases of respiratory cycle; the activity occurred often at peak inspiration and at end-expiration, indicating that a change in the transpulmonary pressure was a contributing factor in their activation (Sant'Ambrogio & Widdicombe, 2001). Finally, he attempted to locate the RAR by inflating a balloon positioned at various points in the airway, and showed that they were predominantly located in the lower portion of the trachea, the carina and the extrapulmonary airways. Even though this procedure activated the receptors, the author remarked that a long lasting regular discharge could not be produced by endo-tracheal stimulation (Widdicombe, 1954).
|
During the course of investigations designed to identify the vagal sensory receptors activated by pulmonary venous congestion, it was found that the RAR were stimulated in an unusual manner (Fig. 2; Kappagoda et al. 1987). The experiments were undertaken in artificially ventilated, anaesthetized dogs, in which the left atrial pressure was increased by 10 mmHg by partly obstructing the mitral valve. This procedure was carried out by inserting a small balloon into the left atrium through the left atrial appendage and inflating the balloon with 35 ml of normal saline. The resulting mitral valve obstruction raised the left atrial pressure. Action potentials from sensory receptors in the lung were recorded from the cervical vagi.
|
This observation suggested that the activity of RAR could be modulated by factors which influence fluid fluxes from the microcirculation of the airways. The anatomical basis for this proposition is the recognition that a significant portion of the venous drainage from the bronchi is directed into the pulmonary veins (Miller, 1947; Harris & Heath, 1986; Wagner et al. 1999). During partial obstruction of the mitral valve, the increase in hydrostatic pressure in the pulmonary veins would raise pressure in the bronchial venules of the proximal airways (Wagner et al. 1998), promoting fluid flux and activation of RAR.
Starling forces and the microcirculation of the lung
The fundamental principle governing the exchange of fluid between microvessels and the extravascular space was proposed by Starling, 1895). He postulated that at any given time, there must be a balance between hydrostatic pressure and the osmotic pressure alteration of the blood ... thereby linking the three main factors which determine the extravascular fluid volume (space) in any tissue, i.e. hydrostatic pressure, oncotic pressure exerted by proteins and the flow of lymph.
Three decades later, these ideas were consolidated further by the experiments of Landis (1930), who summarized his findings in the form of the following equation:
|
|
i are the hydrostatic and plasma oncotic pressures of the interstitial fluid, respectively, Pc and
c are the hydrostatic and oncotic pressures of plasma, respectively, and
is the reflection coefficient of the microvascular wall to plasma protein. If the RAR are responsive to changes in extravascular fluid volume in the lung, it follows that besides hydrostatic pressure, their activity would be influenced by the other factors in the Starling equation, i.e. plasma oncotic pressure and microvascular (capillary) permeability. In addition, they would also be influenced by perturbations of extravascular fluid volume in the airways caused by lymphatic obstruction.
Effect of altering oncotic pressure on RAR activity
Plasmapheresis is a reliable method of reducing the oncotic pressure in plasma. It can be readily performed by removing 1012% of the estimated blood volume of an animal and returning the red blood cells suspended in saline. These procedures decrease the concentration of plasma proteins and thereby reduce the oncotic pressure. Such a reduction enhances the transfer of fluid from the vascular compartment to the extravascular one. This increase in fluid flux is reflected in pulmonary lymph flow. The lymph drainage from the lung occurs mainly via the right lymphatic duct (Courtice & Simmonds, 1954). The right lymphatic ducts open into the venous system in the region where the right internal jugular vein joins the right external jugular vein (Fig. 3).
|
|
|
Histamine. Histamine increases the permeability of the systemic venules and enhances lymph flow (Haddy et al. 1972). In the bronchial circulation, it promotes broncho-venular permeability and causes bronchial oedema (Pietra et al. 1972; Fishman & Pietra, 1976). It has also been shown that infusion of histamine into the right atrium increases pulmonary lymph flow (Ravi et al. 1989). It was found that even subthreshold doses of histamine enhanced the responses of RAR to pulmonary congestion caused by small elevations of left atrial pressure or by pulmonary lymphatic obstruction (Ravi et al. 1989). Also, against a background of pulmonary lymphatic obstruction, the stimulusresponse curve relating histamine and RAR activity was shifted to the left when compared with that elicited in the control state (Ravi et al. 1989; Fig. 6).
|
Angiotensin converting enzyme (ACE) inhibitors and bradykinin. Angiotensin converting enzyme inhibitors are prescribed frequently for the treatment of hypertension and heart failure. Even though ACE inhibitors are tolerated well by the patients, one side-effect that has been reported frequently is a troublesome cough (Semple & Herd, 1986). It has been suggested that the cough is caused by the stimulation of sensory receptors of the airways which are activated by chemicals that accumulate after ACE inhibition. One chemical that has been implicated in the cough response is bradykinin (Williams, 1988). We tested this hypothesis in rabbits using the ACE inhibitor enalapril. It was observed that enalapril given I.V. increased the resting activity of RAR. Additionally, in presence of enalapril, the doseresponse curve relating receptor activity to bradykinin was found to be shifted towards the left, suggesting that the sensitivity of RAR to bradykinin was enhanced by enalapril (Hargreaves et al. 1992).
Bradykinin, which is a powerful vasodilator, increases permeability of bronchial venules when administered into the bronchial circulation (Fishman & Pietra, 1976; Corfield et al. 1991). This effect is mediated by B2 receptors (Mashito et al. 1999). Of the eight RAR investigated in the above study (Hargreaves et al. 1992), the threshold dose of bradykinin required for the stimulation was 0.53 ± 0.11 µg kg1 and that for increasing airway pressure was 1.0 µg kg1. Additionally, at these doses, bradykinin did not stimulate the SAR. The results suggest that besides a direct effect, bradykinin may stimulate RAR indirectly by increasing the permeability of bronchial vasculature.
The findings of a study involving substance P in rabbits also suggest that RAR are sensitive to changes in permeability of capillaries (Bonham et al. 1996). In these experiments, the response of RAR to pulmonary venous congestion was enhanced by substance P.
Effect of lymphatic obstruction on the activity of RAR
The final aspect of the responsiveness of RAR to changes in extravascular fluid volume is the effect of lymphatic obstruction. The lymph drainage from the lung could be obstructed in a reversible manner by creating a pouch from the superior vena cava. A vascularly isolated pouch (length, approximately 3 cm) was created in this region as previously described (Ravi et al. 1988; Hargreaves et al. 1991; Fig. 7). A saline reservoir was connected to the pouch by means of a polyethylene catheter inserted through the axillary vein. The lymph flow was obstructed in a reversible manner by alternately raising the fluid level of the reservoir to a height of 35 cm.
|
Location of RAR
Since there was presumptive evidence that the RAR were sensitive to extravascular fluid fluxes, it was likely that the receptors themselves would be located in the vicinity of the bronchial venules. It is now recognized that a significant proportion of the venous drainage from the bronchial circulation is directed into the pulmonary veins (Kappagoda et al. 1990). For this reason, we examined the bronchi to determine whether there were putative nerve endings in the vicinity of the bronchial venules. This study, which was undertaken in the rat, clearly demonstrated nerve endings located adjacent to the bronchial venules. The sensory nature of these endings was established by demonstrating Wallerian degeneration after cervical vagotomy. These presumptive receptors were ideally located to detect fluid fluxes from the airways. An example of a nerve ending is shown in Fig. 8.
|
The seminal work of Staub and associates established that in heart failure, extravascular fluid accumulates in the lungs and airways according to a well-defined pattern (Staub, 1974; Staub et al. 1967). In the earliest phase of left ventricular dysfunction, fluid accumulates in the airways in the area of the carina and bronchi. When the capacity of the pulmonary lymphatics to drain this fluid is exceeded, it extends into the alveoli, resulting in overt pulmonary oedema. In order to link the activity of RAR to these changes in fluid flux, it was necessary to establish, by direct measurements, the changes in extravascular fluid in the airways under the precise conditions in which the RAR were activated. Using a gravimetric technique, it was possible to show that increases in left atrial pressures of 510 mmHg not only increased the activity of RAR but also increased the extravascular fluid in areas where the RAR were located, i.e. in the carina and proximal bronchi. Simultaneously, it was possible to show that there was no increase in extravascular fluid in the alveoli until the left atrial pressure was in excess of 25 mmHg (Gunawardena et al. 1998, 1999, 2002). These findings are summarized in Table 1. The overall scheme for activation of RAR is shown in Fig. 9.
|
|
Potential relevance to left ventricular dysfunction
In left ventricular dysfunction, pressures in the left atrium and pulmonary veins increase, resulting in pulmonary venous congestion. As the condition progresses and the left atrial pressure exceeds 25 mmHg (Guyton & Lindsay, 1959), alveolar flooding (pulmonary oedema) supervenes. During the early phases of left ventricular dysfunction, i.e. during pulmonary venous congestion, patients complain of dyspnoea on exertion and exhibit a cough or a respiratory wheeze associated with increases in respiratory rate and bronchomotor tone. It is known that procedures which activate RAR also increase respiratory rate, airway tone and airway secretions and cause a cough. It is suggested that the RAR could play a role in generating the symptomatology of left ventricular dysfunction (Ravi & Kappagoda, 1990).
| References |
|---|
|
|
|---|
Adrian
ED (1933). The afferent impulses in the vagus and their effects on respiration. J Physiol
79, 332358.
Bonham AC, Kott KS, Ravi K, Kappagoda CT & Joad JP (1996). Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits. J Physiol 493, 229238.[Medline]
Coleridge HM & Coleridge JC (1994). Pulmonary reflexes: neural mechanisms of pulmonary defense. Annu Rev Physiol 56, 6991.[CrossRef][Medline]
Coleridge
HM, Coleridge
JC
&
Luck
JC (1965). Pulmonary afferent fibres of small diameter stimulated by capsaicin and by hyperinflation of the lungs. J Physiol
179, 248262.
Corfield DR, Webber SE, Hanafi Z & Widdicombe JG (1991). The action of bradykinin and lys-bradykinin on tracheal blood flow and smooth muscle in anesthetized sheep. Pulm Pharmacol 4, 8590.[CrossRef][Medline]
Courtice
FC
&
Simmonds
WJ (1954). Physiological significance of lymph drainage of the serous cavities and lungs. Physiol Rev
34, 419448.
Fishman AP & Pietra GG (1976). Permeability of pulmonary vascular endothelium. Ciba Found Symp 38, 2948.[Medline]
Gunawardena
S, Bravo
E
&
Kappagoda
CT (1998). Effect of chronic mitral valve damage on activity of pulmonary rapidly adapting receptors in the rabbit. J Physiol
511, 7988.
Gunawardena
S, Bravo
E
&
Kappagoda
CT (1999). Rapidly adapting receptors in a rabbit model of mitral regurgitation. J Physiol
521, 739748.
Gunawardena S, Ravi K, Longhurst JC, Kaufman MP, Ma A, Bravo M & Kappagoda CT (2002). Responses of C fiber afferents of the rabbit airways and lungs to changes in extra-vascular fluid volume. Respir Physiol Neurobiol 132, 239251.[CrossRef][Medline]
Guyton
AC
&
Lindsay
AW (1959). Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res
7, 649657.
Haddy
FJ, Scott
JB
&
Grega
GJ (1972). Effects of histamine on lymph protein concentration and flow in the dog forelimb. Am J Physiol
223, 11721177.
Hargreaves
M, Ravi
K
&
Kappagoda
CT (1991). Responses of slowly and rapidly adapting receptors in the airways of rabbits to changes in the Starling forces. J Physiol
432, 8197.
Hargreaves M, Ravi K, Senaratne MP & Kappagoda CT (1992). Responses of airway rapidly adapting receptors to bradykinin before and after administration of enalapril in rabbits. Clin Sci (Lond) 83, 399407.[Medline]
Harris P & Heath D (1986). The Human Pulmonary Circulation, 3rd edn. Churchill Livingstone, New York.
Hughes
R, May
AJ
&
Widdicombe
JG (1956). The output of lymphocytes from the lymphatic system of the rabbit. J Physiol
132, 384390.
Kappagoda
CT, Man
GC
&
Teo
KK (1987). Behaviour of canine pulmonary vagal afferent receptors during sustained acute pulmonary venous pressure elevation. J Physiol
394, 249265.
Kappagoda CT & Ravi K (1989). Plasmapheresis affects responses of slowly and rapidly adapting airway receptors to pulmonary venous congestion in dogs. J Physiol 416, 7991.[Medline]
Kappagoda CT, Skepper JN, McNaughton L, Siew EE & Navaratnam V (1990). Morphology of presumptive rapidly adapting receptors in the rat bronchus. J Anat 168, 265276.[Medline]
Keller VCJ & Loeser A (1930). Ueber die Bedeutung Muskelsinnesorgame fur die Lokomotion und reflektorische Hemmung. Zeitchrift Fur Biologie 89, 373.
Knowlton
GC
&
Larrabee
MG (1946). A unitary analysis of pulmonary volume receptors. Am J Physiol
147, 100114.
Landis EM (1930). Microinjection studies of capillary blood pressure in human skin. Heart 15, 209228.
McCormick
KM, Bravo
EM
&
Kappagoda
CT (2005). Role of adrenergic receptors in the reflex diuresis in rabbits during pulmonary lymphatic obstruction. Exp Physiol
90, 341347.
Mashito Y, Ichinose M & Shirato K (1999). Bradykinin B2 antagonist HOE 140 inhibits late allergic microvascular leakage in guinea pig airways. Immunopharmacology 43, 249253.[Medline]
Miller WS (1947). The Lung. Charles C. Thomas, Springfield, IL, USA.
Paintal
AS (1973). Vagal sensory receptors and their reflex effects. Physiol Rev
53, 159227.
Pietra GG, Szidon JP & Fishman AP (1972). Leaky pulmonary vessels. Trans Assoc Am Physicians 85, 369376.[Medline]
Ravi K, Bonham AC & Kappagoda CT (1994). Effect of pulmonary lymphatic obstruction on respiratory rate and airway rapidly adapting receptor activity in rabbits. J Physiol 480, 163170.[Medline]
Ravi
K
&
Kappagoda
CT (1990). Reflex effects of pulmonary venous congestion: role of vagal afferents. News Physiol Sci
5, 9599.
Ravi K, Teo KK & Kappagoda CT (1988). Stimulation of rapidly adapting pulmonary stretch receptors by pulmonary lymphatic obstruction in dogs. Can J Physiol Pharmacol 66, 630636.[Medline]
Ravi K, Teo KK & Kappagoda CT (1989). Action of histamine on the rapidly adapting airway receptors in the dog. Can J Physiol Pharmacol 67, 14991505.[Medline]
Riccio MM, Myers AC & Undem BJ (1996). Immunomodulation of afferent neurons in guinea-pig isolated airway. J Physiol 491, 499509.[Medline]
Sant'Ambrogio G & Widdicombe J (2001). Reflexes from airway rapidly adapting receptors. Respir Physiol 125, 3345.[CrossRef][Medline]
Semple SR & Herd GW (1986). Cough and wheeze caused by inhibition of angiotensin converting enzyme. N Engl J Med 314, 61.[Medline]
Starling EH (1895). The production and absorption of lymph. In Textbook of Physiology, ed. Schaefer EA, chap. 1, pp. 285311 Pentland, London.
Staub
NC (1974). Pulmonary edema. Physiol Rev
54, 678811.
Staub
NC, Nagano
H
&
Pearce
ML (1967). Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs. J Appl Physiol
22, 227240.
Uhley HN, Leeds SE, Sampson JJ & Friedman M (1960). Right duct lymph flow in dogs measured by a new method. Dis Chest 37, 532534.[Medline]
Undem BJ & Carr MJ (2001). Pharmacology of airway afferent nerve activity. Respir Res 2, 234244.[CrossRef][Medline]
Undem BJ, Carr MJ & Kollarik M (2002). Physiology and plasticity of putative cough fibres in the Guinea pig. Pulm Pharmacol Ther 15, 193198.[CrossRef][Medline]
Wagner
EM, Blosser
S
&
Mitzner
W (1998). Bronchial vascular contribution to lung lymph flow. J Appl Physiol
85, 21902195.
Wagner EM, Mitzner W & Brown RH (1999). Site of functional bronchopulmonary anastomoses in sheep. Anat Record 254, 360366.[CrossRef][Medline]
Widdicombe
J (1954). Receptors in the trachea and bronchi of the cat. J Physiol
123, 71104.
Widdicombe JG (1995). Neurophysiology of the cough reflex. Eur Resp J 8, 11931202.[Abstract]
Widdicombe JG (1999). Advances in understanding and treatment of cough. Monaldi Arch Chest Dis 54, 275279.[Medline]
Widdicombe J (2003). Functional morphology and physiology of pulmonary rapidly adapting receptors (RARs). Anat Record 270, 210.[Medline]
Williams GW (1988). Converting enzyme inhibitors in the treatment of hypertension. N Engl J Med 319, 15171525.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |